These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6211906)

  • 21. Mutagenicity of diatrizoate and other triiodobenzoic acid derivatives in the Ames Salmonella/microsome test.
    Wheeler LA; Norman A; Riley R
    Proc West Pharmacol Soc; 1980; 23():249-53. PubMed ID: 7403138
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutagenicity study of butachlor and its metabolites using Salmonella typhimurium.
    Hsu KY; Lin HJ; Lin JK; Kuo WS; Ou YH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):409-16. PubMed ID: 16341341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico assessment of chemical mutagenesis in comparison with results of Salmonella microsome assay on 909 chemicals.
    Hayashi M; Kamata E; Hirose A; Takahashi M; Morita T; Ema M
    Mutat Res; 2005 Dec; 588(2):129-35. PubMed ID: 16257575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat liver microsome-mediated N-demethylation and mutagenicity of azoxymethane.
    Campbell RL; Suppnick JD; Hettrick JM; Nigro ND
    Cancer Res; 1978 Dec; 38(12):4585-90. PubMed ID: 569014
    [No Abstract]   [Full Text] [Related]  

  • 25. Mutagenicity of dipyridyls and their methylated derivatives in Salmonella typhimurium/rat liver microsome system.
    Lin JK; Huang IH; Lee KW; Lin-Shiau SY
    Proc Natl Sci Counc Repub China B; 1989 Jan; 13(1):56-63. PubMed ID: 2657826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 28. Rat liver microsome-mediated binding to DNA of 3-amino-1-methyl-5H-pyrido[4,3-b]indole, a potent mutagen isolated from tryptophan pyrolysate.
    Hashimoto Y; Takeda K; Shudo K; Okamoto T; Sugimura T; Kosuge T
    Chem Biol Interact; 1978 Oct; 23(1):137-40. PubMed ID: 699188
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the phototoxicity of five antimalarial agents and praziquantel in mice].
    Shao BR; Zhan CQ; Ha SH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):273-5. PubMed ID: 2954378
    [No Abstract]   [Full Text] [Related]  

  • 30. [The embryotoxicity of a new antimalarial pyronaridine in rats].
    Ni YC; Zhan CQ; HA SH; Shao BR
    Yao Xue Xue Bao; 1982 Jun; 17(6):401-6. PubMed ID: 7148461
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spectrofluorometric determination of pyronaridine, an antimalarial].
    Feng Z; Wang CY
    Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):354-7. PubMed ID: 2954399
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacokinetics of pyronaridine, an antimalarial in rabbits].
    Feng Z; Jiang NX; Wang CY; Zhang W
    Yao Xue Xue Bao; 1986 Nov; 21(11):801-5. PubMed ID: 3591314
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure of a base in DNA modified by Glu-P-1.
    Hashimoto Y; Shudo K; Okamoto T
    Chem Pharm Bull (Tokyo); 1979 Oct; 27(10):2532-4. PubMed ID: 527139
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparisons between in vivo and in vitro systems: the in vivo equivalent dose concept.
    Paolini M; Cantelli Forti G; Bauer C
    Mutagenesis; 1988 Nov; 3(6):527-31. PubMed ID: 3070294
    [No Abstract]   [Full Text] [Related]  

  • 35. Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine.
    Kincaid JRA; Kavthe RD; Caravez JC; Takale BS; Thakore RR; Lipshutz BH
    Org Lett; 2022 May; 24(18):3342-3346. PubMed ID: 35504038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of short-term tests for mutagenicity.
    De Serres FJ
    Mutat Res; 1976 Feb; 38(1):1-2. PubMed ID: 1256469
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutagenicity of fluroxene.
    Baden JM; Kelley M; Wharton RS; Hitt BA; Mazze RI
    Anesthesiology; 1976 Dec; 45(6):695. PubMed ID: 10759
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution and excretion of 3H-pyronaridine in mice].
    Feng Z; Wu ZF; Wang CY; Jiang AG
    Yao Xue Xue Bao; 1988; 23(8):629-32. PubMed ID: 3254045
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary metabolites of o-tolidine (3,3'-dimethylbenzidine) and mutagenicity of the metabolites (author's transl)].
    Tanaka K
    Sangyo Igaku; 1981 Mar; 23(2):168-9. PubMed ID: 7265551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biopharmaceutical studies on neuroleptic butyrophenones. IV. Sex differences in the disposition of clofluperol in the rat (author's transl)].
    Aimoto T; Masuda C; Murata T
    Yakugaku Zasshi; 1979 Aug; 99(8):851-4. PubMed ID: 541776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.